Detalhe da pesquisa
1.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Int J Cancer;
154(10): 1794-1801, 2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38312102
2.
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Oncologist;
29(3): e414-e418, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38180954
3.
Environmental and Occupational Exposures and Prognosis in Patients with Non-Muscle Invasive Bladder Cancer in the Be-Well Study.
Am J Epidemiol;
2023 Dec 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38055616
4.
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Breast Cancer Res Treat;
201(1): 117-126, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37326764
5.
The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
Cancer Causes Control;
30(2): 187-193, 2019 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30656539
6.
Current Status of Immunotherapies for Treating Pancreatic Cancer.
Curr Oncol Rep;
21(7): 60, 2019 05 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31101991
7.
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
Cancer;
123(24): 4868-4877, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28881381
8.
Impact of body mass index on ovarian cancer survival varies by stage.
Br J Cancer;
117(2): 282-289, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28588323
9.
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.
Oncologist;
21(10): 1200-1211, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27412392
10.
Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.
Breast Cancer Res Treat;
159(1): 119-29, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27449493
11.
Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).
Cancer Causes Control;
27(3): 391-401, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26797455
12.
History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium.
Am J Epidemiol;
181(12): 944-55, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25925388
13.
A hybrid approach to identify subsequent breast cancer using pathology and automated health information data.
Med Care;
53(4): 380-5, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25769058
14.
Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients.
Oncology;
88(1): 57-68, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25300295
15.
Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium.
Am J Epidemiol;
179(1): 95-111, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24107615
16.
Exploring Death Anxiety and Burnout Among Staff Members Who Work In Outpatient Hemodialysis Units.
Nephrol Nurs J;
41(5): 479-85, 518, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26295090
17.
Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer.
Surg Open Sci;
18: 42-49, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38318322
18.
Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study.
Mol Nutr Food Res;
68(8): e2400087, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38581346
19.
Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study.
JNCI Cancer Spectr;
8(2)2024 Feb 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38627946
20.
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.
Sci Adv;
10(6): eadk1827, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38324679